EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages - Stock Observer
Vir Biotechnology, Inc. $VIR Shares Acquired by Candriam S.C.A. - Zolmax
Vir Biotechnology, Inc. $VIR Shares Bought by Candriam S.C.A.
Vir Biotechnology, Inc. $VIR Stock Holdings Increased by Pictet Asset Management Holding SA - Daily Political
113,028 Shares in Vir Biotechnology, Inc. $VIR Purchased by OP Asset Management Ltd - Stock Observer
Jade Biosciences Appoints Mark Eisner To The Board Of Directors
VirBiotechnology News
Alphabet (GOOGL) Stock Forecast 2026–2030: Where Could Google Stock Go as AI Spending Accelerates?
US Dollar Forecast 2026 (H2 Outlook): Will the USD Stay Strong Through Year-End?
Nvidia Stock Prediction 2030: Will It Hit a $10 Trillion Market Cap?
Week Ahead: The PBoC and the ECB are set to deliver interest rates
Nasdaq 100 Forecast: Index Tests Critical Resistance Amid Cooler Inflation and Resurgent Geopolitical Risks
Latest news
Show more
Gold Price Today, July 23: Gold Holds Above $4,100 as Oil Rally Limits Gains
Fed Rate Decision Preview: Will the Fed Raise Rates at the July 29, 2026 Meeting?
Crude Oil Prices Rise 2% to Six-Week High as US-Iran Tensions Escalate
Bitcoin Price Forecast: BTC Slips as Rising Oil Prices Renew Inflation Concerns
KOSPI Jumps More Than 3% as Alphabet’s $200 Billion AI Plan Lifts Chip Stocks
Tesla 2026 Q2 Earnings: Revenue Surges 26% as AI Investments Weigh on Profits and Cash Flow
